Promising HER2+/HR– breast cancer survival with de-escalated therapyJune 15, 2021Breast CancerOncologyCancer
Genomic signature predicts safety of omitting RT in early breast cancerJune 7, 2021Breast CancerOncology
Pregnancy effect on chemotherapy does not affect maternal breast cancer outcomesJune 7, 2021Breast CancerOncologyWomen's Health
BERENICE: Further evidence of heart safety of dual HER2 blockadeMay 13, 2021Breast CancerOncologyWomen's Health
The power and promise of social media in oncologyMay 3, 2021Breast CancerGenitourinary CancerLung CancerMelanomaOncology
Personalized cancer vaccine shows early promise across tumor typesApril 14, 2021Multiple MyelomaBreast CancerGenitourinary CancerLung CancerOncology
Rankings of most common cancers to shift over next 20 yearsApril 14, 2021Breast CancerLung CancerOncologyMelanoma
Cancer screening stopped by pandemic: Repercussions to come?April 8, 2021Lung CancerBreast CancerCOVID-19 UpdatesMixed TopicsGenitourinary CancerMultiple MyelomaOncology
Huge, struggling breast cancer screening trial gets lifelineMarch 29, 2021Breast CancerWomen's HealthOncology
FDA scrutinizes cancer therapies granted accelerated approvalMarch 18, 2021Breast CancerGenitourinary CancerLung CancerMultiple MyelomaOncologyHealth Policy
